Laura Nijstad

Laura Nijstad is a Researcher at Erasmus MC in the Department of Pharmacy. Her work focuses on pharmacokinetics, drug exposure modeling, and age-related variability in therapeutic outcomes.

• Key research areas: Doxorubicin, Clofarabine, Fludarabine, and Volume of Distribution

Research trends (2024): Recent publications highlight pharmacokinetic analysis of chemotherapy drugs in pediatric and adult populations, emphasizing individualized drug dosing and maturation effects. Sub-fields include population pharmacokinetics, drug outcome assessment, and hematopoietic cell transplantation.